Note 9 - Earnings Per Share (Tables)

3 Months Ended

Sep. 30, 2021

	Quarter Ended September 30,
	2021			2020
Earnings per share – basic:
Net earnings, including noncontrolling interest	$	68,981		$	33,395
Less net earnings (loss) attributable to noncontrolling interest		(634	)		-
Net earnings attributable to Bio-Techne	$	69,615		$	33,395
Income allocated to participating securities		(36	)		(21)
Income available to common shareholders	$	69,579		$	33,374

Weighted-average shares outstanding - basic		39,094			38,536
Earnings per share - basic	$	1.78		$	0.87

Earnings per share – diluted:
Net earnings, including noncontrolling interest	$	68,981		$	33,395
Less net earnings (loss) attributable to noncontrolling interest		(634	)		-
Net earnings attributable to Bio-Techne	$	69,615		$	33,395
Income allocated to participating securities		(36	)		(21	)
Income available to common shareholders	$	69,579		$	33,374

Weighted average shares outstanding - basic		39,094			38,536
Dilutive effect of stock options and restricted stock units		2,064			1,489
Weighted average common shares outstanding - diluted		41,158			40,025
Earnings per share - diluted	$	1.69		$	0.83